Tizanidine (New Horizon Rx Group, LLC)


Welcome to the PulseAid listing for the Tizanidine drug offered from New Horizon Rx Group, LLC. This Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: New Horizon Rx Group, LLC
NON-PROPRIETARY NAME: Tizanidine
SUBSTANCE NAME: TIZANIDINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
ROUTE: ORAL
DOSAGE FORM: TABLET
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2013-08-25
END MARKETING DATE: 0000-00-00


Tizanidine HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTizanidine from New Horizon Rx Group, LLC
LABELER NAME: New Horizon Rx Group, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 4(mg/1)
START MARKETING DATE: 2013-08-25
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58517-380_4ed0bea5-7cc0-4c59-9517-6628c53a27b4
PRODUCT NDC: 58517-380
APPLICATION NUMBER: ANDA076416

Other TIZANIDINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Jubilant Cadista Pharmaceuticals Inc.Tizanidine Hydrochloride
New Horizon Rx Group, LLCTizanidine